Acorda Therapeutics DPO Ratio 2011-2026 | ACOR

Annual DPO Ratio Acorda Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
277	124	103	140	281	181	83.6	101	67	91.9	98.5	153	117

All numbers in USD currency

Maximum	Minimum	Average
281	67	140

2024-Q1	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
157	179	-	80.7	86.7	150	-	113	109	82.6	-	91.1	167	456	-	300	255	390	-	177	147	169	-	83.3	84.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
456	80.7	172

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Heron Therapeutics HRTX	91.4	$ 0.8	2.5 %	$ 133 M	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
Incyte Corporation INCY	200	$ 90.82	0.04 %	$ 17.7 B	USA
BioDelivery Sciences International BDSI	96.3	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	915	-	0.49 %	$ 251 B	Cayman-islands
InMed Pharmaceuticals INM	129	$ 0.79	-3.52 %	$ 1.93 M	Canada
Clovis Oncology CLVS	236	-	-7.23 %	$ 13 M	USA
Compugen Ltd. CGEN	82.7	$ 2.13	1.91 %	$ 199 M	Israel
CorMedix CRMD	79.3	$ 6.35	1.6 %	$ 457 K	USA
Arbutus Biopharma Corporation ABUS	23	$ 4.33	2.12 %	$ 719 M	Canada
Kamada Ltd. KMDA	106	$ 8.33	0.97 %	$ 260 M	Israel